{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:43:01Z","timestamp":1790073781615,"version":"4.0.1"},"reference-count":96,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100021854","name":"Society for Vascular Surgery","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021854","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jvs.2024.12.135","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T23:58:16Z","timestamp":1746057496000},"page":"688-697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A systematic review supporting the Society for Vascular Surgery guideline update on the management of intermittent claudication"],"prefix":"10.1016","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9225-1197","authenticated-orcid":false,"given":"Samer","family":"Saadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9052-5537","authenticated-orcid":false,"given":"Tarek","family":"Nayfeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Rajjoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9531-4990","authenticated-orcid":false,"given":"Bashar","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4713-624X","authenticated-orcid":false,"given":"Mohammed","family":"Firwana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabinda","family":"Jawaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid","family":"Hazem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahrish","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahya","family":"Alsawaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed O.","family":"Seisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry J.","family":"Prokop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Hassan","family":"Murad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2024.12.135_bib1","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","article-title":"Epidemiology of peripheral artery disease","volume":"116","author":"Criqui","year":"2015","journal-title":"Circ Res"},{"issue":"Suppl S","key":"10.1016\/j.jvs.2024.12.135_bib2","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2024.12.135_bib3","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jvs.2017.05.105","article-title":"Data, guidelines, and practice of revascularization for claudication","volume":"66","author":"Conte","year":"2017","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2024.12.135_bib4","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1161\/CIRCRESAHA.121.318261","article-title":"Advances in revascularization for peripheral artery disease: revascularization in PAD","volume":"128","author":"Beckman","year":"2021","journal-title":"Circ Res"},{"issue":"3 Suppl","key":"10.1016\/j.jvs.2024.12.135_bib5","doi-asserted-by":"crossref","first-page":"54s","DOI":"10.1016\/j.jvs.2014.12.007","article-title":"A systematic review of treatment of intermittent claudication in the lower extremities","volume":"61","author":"Malgor","year":"2015","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2024.12.135_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.jvs.2024.12.135_bib7","first-page":"21","article-title":"Rivaroxaban and aspirin in patients with symptomatic lower extremity peripheral artery disease: a subanalysis of the COMPASS randomized clinical trial","volume":"6","author":"Kaplovitch","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jvs.2024.12.135_bib8","doi-asserted-by":"crossref","first-page":"e1035","DOI":"10.1097\/SLA.0000000000004712","article-title":"Long-term follow-up of a randomized clinical trial comparing endovascular revascularization plus supervised exercise with supervised exercise only for intermittent claudication","volume":"276","author":"Klaphake","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.jvs.2024.12.135_bib9","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.2021.2536","article-title":"Effect of low-intensity vs high-intensity home-based walking exercise on walk distance in patients with peripheral artery disease: the LITE randomized clinical trial","volume":"325","author":"McDermott","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2024.12.135_bib10","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1056\/NEJMoa2005206","article-title":"Mortality with paclitaxel-coated devices in peripheral artery disease","volume":"383","author":"Nordanstig","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvs.2024.12.135_bib11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/1358863X20988360","article-title":"Microcrystalline paclitaxel-coated balloon for revascularization of femoropopliteal artery disease: three-year outcomes of the randomized BIOPAC trial","volume":"26","author":"Nowakowski","year":"2021","journal-title":"Vasc Med"},{"key":"10.1016\/j.jvs.2024.12.135_bib12","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jcin.2021.03.021","article-title":"1-year results from the RANGER II SFA randomized trial of the ranger drug-coated balloon","volume":"14","author":"Sachar","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2024.12.135_bib13","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1177\/1526602820948240","article-title":"Three-year results of the IN.PACT SFA Japan trial comparing drug-coated balloons with percutaneous transluminal angioplasty","volume":"27","author":"Soga","year":"2020","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jvs.2024.12.135_bib14","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s00270-019-02309-3","article-title":"The randomized freeway stent study: drug-eluting balloons outperform standard balloon angioplasty for postdilatation of nitinol stents in the SFA and PI segment","volume":"42","author":"Tacke","year":"2019","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvs.2024.12.135_bib15","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jvs.2021.01.041","article-title":"Long-term safety and efficacy of angioplasty of femoropopliteal artery disease with drug-coated balloons from the AcoArt I trial","volume":"74","author":"Xu","year":"2021","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2024.12.135_bib16","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jvs.2024.12.135_bib17","author":"Wells"},{"key":"10.1016\/j.jvs.2024.12.135_bib18","first-page":"60","article-title":"Methodological quality and synthesis of case series and case reports","volume":"23","author":"Murad","year":"2018","journal-title":"Evidence-Based Med"},{"key":"10.1016\/j.jvs.2024.12.135_bib19","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.mayocp.2017.01.001","article-title":"Clinical practice guidelines: a primer on development and dissemination","volume":"92","author":"Murad","year":"2017","journal-title":"Mayo Clinic Proc"},{"key":"10.1016\/j.jvs.2024.12.135_bib20","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jvs.2011.01.036","article-title":"Guideline methodology of the Society for Vascular Surgery including the experience with the GRADE framework","volume":"53","author":"Murad","year":"2011","journal-title":"J Vasc Surg"},{"issue":"5 SUPPL","key":"10.1016\/j.jvs.2024.12.135_bib21","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.jvs.2008.08.045","article-title":"Methodology for clinical practice guidelines for the management of arteriovenous access","volume":"48","author":"Murad","year":"2008","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2024.12.135_bib22","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. rating the quality of evidence - imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jvs.2024.12.135_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"key":"10.1016\/j.jvs.2024.12.135_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v049.i05","article-title":"Closing the gap between methodologists and end-users: R as a computational back-end","volume":"49","author":"Wallace","year":"2012","journal-title":"J Stat Softw"},{"key":"10.1016\/j.jvs.2024.12.135_bib25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.avsg.2018.07.046","article-title":"Remote ischemic pre-conditioning in the management of intermittent claudication: a pilot randomized controlled trial","volume":"55","author":"Ahmed","year":"2019","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2024.12.135_bib26","doi-asserted-by":"crossref","first-page":"H1495","DOI":"10.1152\/ajpheart.00151.2019","article-title":"Heat therapy vs. supervised exercise therapy for peripheral arterial disease: a 12-wk randomized, controlled trial","volume":"316","author":"Akerman","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jvs.2024.12.135_bib27","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1007\/s00270-018-1940-1","article-title":"Two-year clinical outcomes of the CONSEQUENT trial: can femoropopliteal lesions be treated with sustainable clinical results that are economically sound?","volume":"41","author":"Albrecht","year":"2018","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvs.2024.12.135_bib28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(17)32409-1","article-title":"Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Anand","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2024.12.135_bib29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.avsg.2019.08.073","article-title":"Factors associated with amputation after peripheral vascular intervention for intermittent claudication","volume":"62","author":"Axley","year":"2020","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2024.12.135_bib30","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.ejvs.2018.10.021","article-title":"Population based analysis of gender disparities in 23,715 percutaneous endovascular revascularisations in the metropolitan area of hamburg","volume":"57","author":"Behrendt","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2024.12.135_bib31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/1358863X18804050","article-title":"Brachial artery intima-media thickness and grayscale texture changes in patients with peripheral artery disease receiving supervised exercise training in the PROPEL randomized clinical trial","volume":"24","author":"Berroug","year":"2019","journal-title":"Vasc Med"},{"key":"10.1016\/j.jvs.2024.12.135_bib32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/pri.1608","article-title":"Effects of 12 weeks of supervised exercise after endovascular treatment: a randomized clinical trial","volume":"20","author":"Bo","year":"2015","journal-title":"Physiother Res Int"},{"key":"10.1016\/j.jvs.2024.12.135_bib33","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0140-6736(99)07199-8","article-title":"Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2024.12.135_bib34","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvs.2024.12.135_bib35","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1161\/CIRCULATIONAHA.112.000679","article-title":"Vorapaxar in patients with peripheral artery disease: results from TRA2degreesP-TIMI 50","volume":"127","author":"Bonaca","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2024.12.135_bib36","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jcin.2018.08.034","article-title":"Sustainable antirestenosis effect with a low-dose drug-coated balloon: the ILLUMENATE European randomized clinical trial 2-year results","volume":"11","author":"Brodmann","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2024.12.135_bib37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12933-020-01072-x","article-title":"Influence of preprocedural glycemic control on clinical outcomes of endovascular therapy in diabetic patients with lower extremity artery disease: an analysis from a Korean multicenter retrospective registry cohort","volume":"19","author":"Cha","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jvs.2024.12.135_bib38","first-page":"1055","article-title":"Percutaneous revascularization of long femoral artery lesions for claudication: patency over 2.5 years and impact of systematic surveillance","volume":"77","author":"Connors","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2024.12.135_bib39","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.115.016900","article-title":"Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial","volume":"133","author":"Dake","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2024.12.135_bib40","doi-asserted-by":"crossref","DOI":"10.1177\/2042018820960294","article-title":"Worse cardiovascular prognosis after endovascular surgery for intermittent claudication caused by infrainguinal atherosclerotic disease in patients with diabetes","volume":"11","author":"Dakhel","year":"2020","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.jvs.2024.12.135_bib41","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S1078-5884(98)80048-8","article-title":"Vascular morbidity and mortality during long-term follow-up in claudicants selected for peripheral bypass surgery","volume":"16","author":"Dawson","year":"1998","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2024.12.135_bib42","first-page":"679","article-title":"Drug coated balloon supported Supera stent versus Supera stent in intermediate and long-segment lesions of the superficial femoral artery: 2-year results of the RAPID Trial","volume":"60","author":"de Boer","year":"2019","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.jvs.2024.12.135_bib43","article-title":"Absence of long-term benefit of revascularization in patients with intermittent claudication: five-year results from the IRONIC randomized controlled trial","volume":"13","author":"Djerf","year":"2020","journal-title":"Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2024.12.135_bib44","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijcard.2020.01.024","article-title":"Ticagrelor versus clopidogrel in patients undergoing implantation of paclitaxel-eluting stent in the femoropopliteal district: a randomized pilot study using frequency-domain optical coherence tomography","volume":"304","author":"Ducci","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jvs.2024.12.135_bib45","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1583\/05-1704.1","article-title":"Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial","volume":"13","author":"Duda","year":"2006","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jvs.2024.12.135_bib46","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1001\/jama.2015.14851","article-title":"Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial","volume":"314","author":"Fakhry","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2024.12.135_bib47","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.jvs.2018.06.193","article-title":"Major adverse limb events and major adverse cardiac events after contemporary lower extremity bypass and infrainguinal endovascular intervention in patients with claudication","volume":"68","author":"Fashandi","year":"2018","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2024.12.135_bib48","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S1078-5884(03)00318-6","article-title":"Long term prognosis in patients with peripheral arterial disease treated with antiplatelet agents","volume":"26","author":"Fiotti","year":"2003","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2024.12.135_bib49","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001107","article-title":"Step-monitored home exercise improves ambulation, vascular function, and inflammation in symptomatic patients with peripheral artery disease: a randomized controlled trial","volume":"3","author":"Gardner","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jvs.2024.12.135_bib50","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/030006059001800508","article-title":"Treatment of intermittent claudication with antiplatelet agents","volume":"18","author":"Giansante","year":"1990","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jvs.2024.12.135_bib51","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1611688","article-title":"Ticagrelor versus clopidogrel in symptomatic peripheral artery disease","volume":"376","author":"Hiatt","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvs.2024.12.135_bib52","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.jfma.2019.10.011","article-title":"Contemporary cardiovascular outcomes in Taiwanese patients undergoing endovascular therapy for symptomatic lower extremity peripheral arterial disease","volume":"119","author":"Huang","year":"2020","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jvs.2024.12.135_bib53","doi-asserted-by":"crossref","first-page":"7961","DOI":"10.3390\/ijerph110807961","article-title":"Effectiveness of a new exercise program after lower limb arterial blood flow surgery in patients with peripheral arterial disease: a randomized clinical trial","volume":"11","author":"Jakubseviciene","year":"2014","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jvs.2024.12.135_bib54","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1067\/mva.2003.148","article-title":"Infrainguinal revascularization because of claudication: total long-term outcome of endovascular and surgical treatment","volume":"37","author":"Jamsen","year":"2003","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2024.12.135_bib55","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.avsg.2014.07.028","article-title":"Safety and effectiveness of endovascular therapy for claudication in octogenarians","volume":"29","author":"Jones","year":"2015","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2024.12.135_bib56","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00270-016-1513-0","article-title":"Peripheral stent thrombosis leading to acute limb ischemia and major amputation: incidence and risk factors in the aortoiliac and femoropopliteal arteries","volume":"40","author":"Katsanos","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvs.2024.12.135_bib57","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1583\/13-4625R.1","article-title":"German multicenter real-world registry of stenting for superficial femoral artery disease: clinical results and predictive factors for revascularization","volume":"21","author":"Krankenberg","year":"2014","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jvs.2024.12.135_bib58","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/CIRCULATIONAHA.117.028893","article-title":"Stellarex drug-coated balloon for treatment of femoropopliteal disease: twelve-month outcomes from the randomized ILLUMENATE pivotal and pharmacokinetic studies","volume":"136","author":"Krishnan","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2024.12.135_bib59","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.007702","article-title":"Long-term clinical effectiveness of a drug-coated balloon for the treatment of femoropopliteal lesions","volume":"12","author":"Laird","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2024.12.135_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1583\/11-3627.1","article-title":"Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial","volume":"19","author":"Laird","year":"2012","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jvs.2024.12.135_bib61","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1177\/0003319715618481","article-title":"Structured home-based exercise versus invasive treatment: a mission impossible? A pilot randomized study in elderly patients with intermittent claudication","volume":"67","author":"Lamberti","year":"2016","journal-title":"Angiology"},{"key":"10.1016\/j.jvs.2024.12.135_bib62","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jvs.2016.12.141","article-title":"Comparative effectiveness of anticoagulation on midterm infrainguinal bypass graft patency","volume":"66","author":"Liang","year":"2017","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2024.12.135_bib63","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1089\/jwh.2018.7113","article-title":"Gender differences in outcomes following a pain-free, home-based exercise program for claudication","volume":"28","author":"Manfredini","year":"2019","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.jvs.2024.12.135_bib64","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/bjs.10324","article-title":"Long-term outcomes of a randomized clinical trial of supervised exercise, percutaneous transluminal angioplasty or combined treatment for patients with intermittent claudication due to femoropopliteal disease","volume":"104","author":"Mazari","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.jvs.2024.12.135_bib65","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000711","article-title":"Home-based walking exercise in peripheral artery disease: 12-month follow-up of the GOALS randomized trial","volume":"3","author":"McDermott","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jvs.2024.12.135_bib66","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1001\/jama.2018.3275","article-title":"Effect of a home-based exercise intervention of wearable technology and telephone coaching on walking performance in peripheral artery disease: the HONOR Randomized clinical trial","volume":"319","author":"McDermott","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2024.12.135_bib67","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/0003319711414866","article-title":"Clinical outcomes after endovascular treatment of superficial femoral disease in patients with disabling claudication and critical limb ischemia: midterm analysis","volume":"63","author":"Misselt","year":"2012","journal-title":"Angiology"},{"key":"10.1016\/j.jvs.2024.12.135_bib68","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1583\/13-4618R.1","article-title":"Five-year prognosis after endovascular therapy in claudicant patients with iliofemoral artery disease","volume":"21","author":"Miura","year":"2014","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jvs.2024.12.135_bib69","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jvs.2016.07.118","article-title":"Revascularization of smokers with claudication is not predicted to limit quality of life despite a higher risk of late failure","volume":"65","author":"Mixson","year":"2017","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2024.12.135_bib70","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.avsg.2020.08.097","article-title":"Prevalence and outcomes of endovascular infrapopliteal interventions for intermittent claudication","volume":"70","author":"Mullins","year":"2021","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2024.12.135_bib71","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/bjs.10198","article-title":"Two-year results from a randomized clinical trial of revascularization in patients with intermittent claudication","volume":"103","author":"Nordanstig","year":"2016","journal-title":"Br J Surg"},{"key":"10.1016\/j.jvs.2024.12.135_bib72","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1161\/CIRCULATIONAHA.116.025329","article-title":"Randomized comparison of paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH)","volume":"135","author":"Ott","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2024.12.135_bib73","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jvs.2020.04.498","article-title":"Clinical characteristics and response to supervised exercise therapy of people with lower extremity peripheral artery disease","volume":"73","author":"Patel","year":"2021","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2024.12.135_bib74","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacc.2012.04.035","article-title":"Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents: long-term results from a randomized trial","volume":"60","author":"Rastan","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2024.12.135_bib75","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel-coated balloon for femoropopliteal artery disease","volume":"373","author":"Rosenfield","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvs.2024.12.135_bib76","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcin.2013.05.022","article-title":"The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty","volume":"7","author":"Scheinert","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2024.12.135_bib77","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jvs.2011.10.128","article-title":"Results for primary bypass versus primary angioplasty\/stent for intermittent claudication due to superficial femoral artery occlusive disease","volume":"55","author":"Siracuse","year":"2012","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2024.12.135_bib78","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1253\/circj.CJ-10-0077","article-title":"Long-term clinical outcome after endovascular treatment in patients with intermittent claudication due to iliofemoral artery disease","volume":"74","author":"Soga","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.jvs.2024.12.135_bib79","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/bjs.9519","article-title":"Randomized clinical trial comparing Nordic pole walking and a standard home exercise programme in patients with intermittent claudication","volume":"101","author":"Spafford","year":"2014","journal-title":"Br J Surg"},{"key":"10.1016\/j.jvs.2024.12.135_bib80","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jcin.2018.01.276","article-title":"12-month results from the first-in-human randomized study of the ranger paclitaxel-coated balloon for femoropopliteal treatment","volume":"11","author":"Steiner","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2024.12.135_bib81","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jvs.2014.03.254","article-title":"C-reactive protein and brain natriuretic peptide as predictors of adverse events after lower extremity endovascular revascularization","volume":"60","author":"Stone","year":"2014","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2024.12.135_bib82","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1148\/radiol.2020191619","article-title":"Drug-coated balloon angioplasty of femoropopliteal lesions maintained superior efficacy over conventional balloon: 2-year results of the randomized EffPac trial","volume":"295","author":"Teichgraber","year":"2020","journal-title":"Radiology"},{"issue":"1 Pt A","key":"10.1016\/j.jvs.2024.12.135_bib83","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jcin.2014.07.023","article-title":"Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial","volume":"8","author":"Tepe","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2024.12.135_bib84","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1177\/1526602820931477","article-title":"Three-year sustained clinical efficacy of drug-coated balloon angioplasty in a real-world femoropopliteal cohort","volume":"27","author":"Torsello","year":"2020","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jvs.2024.12.135_bib85","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.rehab.2020.03.004","article-title":"Short interval or continuous training programs to improve walking distance for intermittent claudication: Pilot study","volume":"63","author":"Villemur","year":"2020","journal-title":"Ann Phys Rehabil Med"},{"key":"10.1016\/j.jvs.2024.12.135_bib86","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/CIRCINTERVENTIONS.112.971630","article-title":"Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial","volume":"5","author":"Werk","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2024.12.135_bib87","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1161\/CIRCULATIONAHA.107.735985","article-title":"Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial","volume":"118","author":"Werk","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2024.12.135_bib88","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejvs.2007.02.009","article-title":"Association of circulating transforming growth factor beta, tumor necrosis factor alpha and basic fibroblast growth factor with restenosis after transluminal angioplasty","volume":"34","author":"Wildgruber","year":"2007","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2024.12.135_bib89","doi-asserted-by":"crossref","first-page":"e1313","DOI":"10.1161\/CIR.0000000000001251","article-title":"2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS guideline for the management of lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"149","author":"Gornik","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2024.12.135_bib90","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejvs.2023.08.067","article-title":"Editor's choice -- European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines on the management of asymptomatic lower limb peripheral arterial disease and intermittent claudication","volume":"67","author":"Nordanstig","year":"2024","journal-title":"Eur J Vasc Endovascular Surg"},{"issue":"3 Suppl","key":"10.1016\/j.jvs.2024.12.135_bib91","doi-asserted-by":"crossref","first-page":"2s","DOI":"10.1016\/j.jvs.2014.12.009","article-title":"Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication","volume":"61","author":"Conte","year":"2015","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2024.12.135_bib92","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.jacc.2024.06.027","article-title":"Antithrombotic strategies for patients with peripheral artery disease: JACC scientific statement","volume":"84","author":"Bonaca","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2024.12.135_bib93","first-page":"655","article-title":"Atherectomy of the femoropopliteal artery: a systematic review and meta-analysis of randomized controlled trials","volume":"55","author":"Diamantopoulos","year":"2014","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.jvs.2024.12.135_bib94","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejvs.2024.08.002","article-title":"Systematic review and network meta-analysis of vessel preparation techniques with plain balloon angioplasty, atherectomy, or intravascular lithotripsy before application of a drug coated balloon to treat atherosclerotic femoropopliteal disease","volume":"69","author":"Yiu","year":"2024","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2024.12.135_bib95","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jvs.2020.10.090","article-title":"Intermittent claudication treatment patterns in the commercially insured non-Medicare population","volume":"74","author":"Siracuse","year":"2021","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2024.12.135_bib96","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jvs.2022.08.033","article-title":"Practice patterns surrounding the use of tibial interventions for claudication in the Medicare population","volume":"77","author":"Bose","year":"2023","journal-title":"J Vasc Surg"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074152142501002X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074152142501002X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T18:35:16Z","timestamp":1754073316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074152142501002X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":96,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S074152142501002X"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2024.12.135","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review supporting the Society for Vascular Surgery guideline update on the management of intermittent claudication","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2024.12.135","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2025.04.041","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Society for Vascular Surgery. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}